Speedus Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPDE research report →
Price Chart
About the company
Speedus Corp. , through its subsidiaries, engages in the development of diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists, and other healthcare professionals in the United States. The company offers computer-aided medical devices and telemedicine based delivery systems, including Zargis Cardioscan device, a non-invasive diagnostic support solution that automatically analyzes acoustical data from a patient to determine whether or not the patient possesses a suspected diastolic or systolic murmur; ZargisTelemed portal; and Signal X6 device, which records heart and lung sounds from six adhesive acoustic sensors.
- CEO
- Shant S. Hovnanian
- IPO
- 1996
- Employees
- 20
- HQ
- Freehold, NJ, US
Get TickerSpark's AI analysis on SPDE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $416
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.11
- Div Yield
- 0.00%
- Gross Margin
- 63.93%
- Op Margin
- -763.35%
- Net Margin
- -616.64%
- ROE
- -150.94%
- ROIC
- -192.56%
Latest fiscal year · YoY change
- Revenue
- $461.18K+195.9%
- Gross Profit
- $294.85K+134.9%
- Op Income
- $-3,520,393
- Net Income
- $-2,843,795+69.1%
- EPS
- $-0.72+68.8%
- OCF Growth
- +27.5%
- FCF Growth
- +27.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 52.56
- RSI (14)
- 52
- Avg Volume
- 922
No earnings-call transcripts are available for SPDE yet.
- Free Float
- 99.5%
- Shares Outstanding
- 4.16M
- Float Shares
- 4.14M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 26, 10 | Kallassy John A | other | 70,000 |
| Jun 11, 10 | Kallassy John A | other | 20,000 |
| Jun 11, 10 | Kallassy John A | sell | 20,000 |
| Oct 21, 09 | Kallassy John A | other | 30,000 |
| Oct 21, 09 | Kallassy John A | sell | 30,000 |
| Aug 14, 09 | Kallassy John A | other | 50,000 |
| Dec 31, 08 | Kallassy John A | other | 0 |
| Dec 31, 08 | Leimkuhler William F. | other | 0 |
| Nov 20, 08 | Leimkuhler William F. | other | 2,500 |
| Dec 31, 07 | Leimkuhler William F. | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SPDE coverage
Recent articles, reports, and earnings notes.
No research on SPDE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SPDE report →